Clonidine
(KLO-nih-deen)
Definition | Special instructions | Missed dose | Side effects | Warning signs | Contact us
What is clonidine?
Clonidine (Catapres") belongs to a class of medications known as antihypertensives. It is used for the management of hypertension (high blood pressure). It can be used in children for a condition known as Attention Deficit Hyperactivity Disorder (ADHD). It may also be used in combination with other pain medication for treating certain kinds of pain. It is available as a tablet, as a patch applied to the skin or your pharmacist may be able to make a liquid.
Special Instructions
Give this medication as directed, and do not stop taking unless directed to stop by your child's doctor.
Notify your child's doctor of any other medications your child is taking.
Let your child's doctor know if your child has a
heart condition or kidney disorder prior to giving this medicine.
It is best to avoid alcohol or over the counter medications that contain alcohol while taking this medication.
The patches should be applied at bedtime to a clean, hairless area of the upper arms or chest.
Rotate where the patch is applied weekly. Do not cut the patches.
Do not use after the expiration date on the bottle/package.
If too much medication is taken by accident, call the Drug and Poison Information Center (DPIC), 513-636-5111 or 1-800-222-1222, or call your child's doctor immediately.
Keep this medication out of the reach of children.
Back to top
If a Dose is Missed
For any medication information related to your child's dosing schedule and/or missed doses, contact the healthcare provider who prescribed the medication.
Side Effects
Call your child's doctor if the following effects continue or are bothersome:
Drowsiness
Dizziness
Fatigue
Headache
Dry mouth
Back to top
Warning Signs
Call your child's doctor immediately if your child develops any of the following:
Back to top
Contact us
For additional information on this or any Health Topic, please call the Family Resource Center, 513-636-7606, or your pediatrician.
Back to top
Patient Education Program V 5035 1/00
rev. 9/05, 8/07
